Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Deraco

Showing results (121-130 of 178) with videos related to

Pageof 18
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 10, 2020
Hemodynamic and respiratory implications of high intra-abdominal pressure during HIPECArtur C V Reis, Shigeki Kusamura, Norfarizan Azmi, et al.
Cancer|April 22, 2011
A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database*Tristan D Yan, Marcello Deraco, Dominique Elias, et al.
Oncotarget|May 8, 2015
Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivinMichelandrea De Cesare, Denis Cominetti, Valentina Doldi, et al.
In Vivo (Athens, Greece)|January 6, 2007
Tubular dysfunction after peritonectomy and chemohyperthermic treatment with cisplatinGaetano La Manna, Salvatore Virzì, Marcello Deraco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesotheliomaRaffaella Villa, Maria Grazia Daidone, Rosita Motta, et al.
Journal of Surgical Oncology|August 16, 2025
Multisocietal Consensus on the use of Cytoreductive Surgery and HIPEC for the Treatment of Pseudomyxoma Peritonei: A GRADE Approach for Evidence Evaluation and RecommendationShigeki Kusamura, Edward Levine, Michela Cinquini, et al.
Journal of Surgical Oncology|October 3, 2024
A combinatorial culture strategy to develop pseudomyxoma peritonei organoid modelsLuca Varinelli, Marzia Di Bella, Marcello Guaglio, et al.
Journal of Surgical Oncology|October 25, 2024
Guidelines for the Prophylaxis and Treatment of Peritoneal Metastases From Colorectal Cancer: A GRADE-Approach for Evidence Evaluation and RecommendationsDiane Goéré, Shigeki Kusamura, Robin J Lurvink, et al.
Cancers|February 11, 2023
Diagnostic and Therapeutic Pathway in Diffuse Malignant Peritoneal MesotheliomaShigeki Kusamura, Dario Baratti, Michele De Simone, et al.
Journal of Translational Medicine|May 22, 2026
FASN for diffuse malignant peritoneal mesothelioma: a prognostic biomarker after CRS+HIPEC and a therapeutic targetValentina Doldi, Chiara Maura Ciniselli, Claudia Aurelio, et al.
Pageof 18

Showing results (121-130 of 178) with videos related to

Sort By:
Pageof 18
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 10, 2020
Hemodynamic and respiratory implications of high intra-abdominal pressure during HIPECArtur C V Reis, Shigeki Kusamura, Norfarizan Azmi, et al.
Cancer|April 22, 2011
A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database*Tristan D Yan, Marcello Deraco, Dominique Elias, et al.
Oncotarget|May 8, 2015
Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivinMichelandrea De Cesare, Denis Cominetti, Valentina Doldi, et al.
In Vivo (Athens, Greece)|January 6, 2007
Tubular dysfunction after peritonectomy and chemohyperthermic treatment with cisplatinGaetano La Manna, Salvatore Virzì, Marcello Deraco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesotheliomaRaffaella Villa, Maria Grazia Daidone, Rosita Motta, et al.
Journal of Surgical Oncology|August 16, 2025
Multisocietal Consensus on the use of Cytoreductive Surgery and HIPEC for the Treatment of Pseudomyxoma Peritonei: A GRADE Approach for Evidence Evaluation and RecommendationShigeki Kusamura, Edward Levine, Michela Cinquini, et al.
Journal of Surgical Oncology|October 3, 2024
A combinatorial culture strategy to develop pseudomyxoma peritonei organoid modelsLuca Varinelli, Marzia Di Bella, Marcello Guaglio, et al.
Journal of Surgical Oncology|October 25, 2024
Guidelines for the Prophylaxis and Treatment of Peritoneal Metastases From Colorectal Cancer: A GRADE-Approach for Evidence Evaluation and RecommendationsDiane Goéré, Shigeki Kusamura, Robin J Lurvink, et al.
Cancers|February 11, 2023
Diagnostic and Therapeutic Pathway in Diffuse Malignant Peritoneal MesotheliomaShigeki Kusamura, Dario Baratti, Michele De Simone, et al.
Journal of Translational Medicine|May 22, 2026
FASN for diffuse malignant peritoneal mesothelioma: a prognostic biomarker after CRS+HIPEC and a therapeutic targetValentina Doldi, Chiara Maura Ciniselli, Claudia Aurelio, et al.
Pageof 18